FLXN
COM:FLEXIONTHERAPEUTICS
Flexion Therapeutics
- Stock
Last Close
9.12
01/01 00:00
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 899.50K - | 4.72M 424.51% | 12.08M 156.10% | 15.96M 32.10% | ||||
average payables | 1.43M - | 2.64M 84.22% | 2.93M 10.92% | 4.19M 43.22% | 9.28M 121.43% | 13.80M 48.68% | 11.09M 19.61% | |
average receivables | 124.91K - | 376.83K 201.69% | 570.92K 51.51% | 996.40K 74.52% | 7.61M 664.05% | 25.60M 236.21% | 33.81M 32.10% | |
book value per share | 10.43 - | 4.84 53.63% | 7.39 52.85% | 7.88 6.59% | 2.92 63.00% | -0.53 118.11% | -0.39 26.23% | |
capex per share | -0.06 - | -0.24 318.59% | -0.33 37.99% | -0.06 80.52% | -0.02 65.27% | -0.10 353.02% | -0.24 130.23% | |
capex to depreciation | -6.67 - | -21.82 227.27% | -7.33 66.40% | -1.07 85.43% | -0.50 53.49% | -1.63 226.95% | -3.01 85.38% | |
capex to operating cash flow | 0.03 - | 0.13 284.87% | 0.14 1.24% | 0.02 85.27% | 0.01 73.31% | 0.03 392.87% | 0.14 445.14% | |
capex to revenue | -6.05 - | -0.04 99.37% | -0.05 41.10% | -0.12 120.51% | ||||
cash per share | 10.91 - | 5.17 52.58% | 8.13 57.06% | 11.88 46.17% | 6.86 42.30% | 3.59 47.66% | 4.10 14.20% | |
days of inventory on hand | 164.16K - | 379.98 99.77% | 605.73 59.41% | 291.90 51.81% | ||||
days payables outstanding | 567.76K - | 613.97 99.89% | 559.15 8.93% | 131.37 76.51% | ||||
days sales outstanding | 1.43K - | 224.24 84.29% | 186.88 16.66% | 129.15 30.89% | ||||
debt to assets | 0.05 - | 0.18 231.13% | 0.17 4.79% | 0.41 136.60% | 0.63 53.03% | 1.09 74.01% | 1.07 2.41% | |
debt to equity | 0.06 - | 0.22 282.59% | 0.21 5.79% | 0.70 231.62% | 1.69 142.49% | -11.82 800.74% | -16.12 36.40% | |
dividend yield | ||||||||
earnings yield | -0.10 - | -0.11 14.83% | -0.15 33.65% | -0.17 11.25% | -0.40 138.82% | -0.19 52.15% | -0.23 21.25% | |
enterprise value | 181.02M - | 414.61M 129.05% | 480.76M 15.95% | 859.22M 78.72% | 498.60M 41.97% | 901.07M 80.72% | 611.16M 32.17% | |
enterprise value over ebitda | -6.76 - | -9.11 34.85% | -6.97 23.52% | -6.92 0.72% | -3.28 52.65% | -6.91 111.12% | -6.80 1.62% | |
ev to operating cash flow | -7.82 - | -10.65 36.11% | -7.70 27.71% | -7.97 3.54% | -3.11 60.99% | -6.06 94.89% | -8.66 42.99% | |
ev to sales | 2.42K - | 22.14 99.09% | 12.35 44.21% | 7.14 42.16% | ||||
free cash flow per share | -1.72 - | -2.05 19.15% | -2.80 36.50% | -3.33 18.79% | -4.27 28.29% | -4.01 6.18% | -1.88 52.97% | |
free cash flow yield | -0.09 - | -0.11 24.83% | -0.15 38.30% | -0.13 9.77% | -0.38 183.78% | -0.19 48.69% | -0.16 15.64% | |
graham net net | 10.32 - | 4.12 60.10% | 6.59 60.20% | 6.46 2.08% | 2.31 64.19% | -1.70 173.49% | -1.47 13.47% | |
graham number | 21.48 - | 15.31 28.71% | 21.74 41.99% | 27.17 24.95% | 17.17 36.80% | 6.83 60.20% | 4.83 29.39% | |
income quality | 0.85 - | 0.84 0.76% | 0.87 3.33% | 0.78 9.74% | 0.95 20.55% | 0.99 5.04% | 0.62 37.52% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -67.24 - | -80.67 19.98% | -39.94 50.49% | -11.51 71.18% | -10.13 11.96% | -7.98 21.19% | -4.64 41.83% | |
interest debt per share | 0.29 - | 0.72 151.96% | 1.28 76.15% | 5.19 306.41% | 4.61 11.02% | 5.57 20.63% | 5.73 3.00% | |
inventory turnover | 0.00 - | 0.96 43,102.38% | 0.60 37.27% | 1.25 107.51% | ||||
invested capital | 0.02 - | 0.14 481.93% | 0.16 13.16% | 0.61 276.59% | 1.44 134.19% | -9.69 773.36% | -13.52 39.45% | |
market cap | 280.52M - | 414.25M 47.67% | 481.14M 16.15% | 827.00M 71.88% | 427.34M 48.33% | 788.38M 84.48% | 493.64M 37.39% | |
net current asset value | 143.69M - | 88.95M 38.10% | 170.16M 91.30% | 216.95M 27.49% | 99.37M 54.20% | -41.99M 142.26% | -42.77M 1.86% | |
net debt to ebitda | 3.71 - | -0.01 100.21% | 0.01 170.00% | -0.26 4,778.30% | -0.47 80.43% | -0.86 84.75% | -1.31 51.28% | |
net income per share | -1.97 - | -2.15 9.60% | -2.84 31.91% | -4.16 46.47% | -4.49 7.96% | -3.93 12.50% | -2.66 32.40% | |
operating cash flow per share | -1.67 - | -1.81 8.76% | -2.47 36.30% | -3.26 32.21% | -4.25 30.15% | -3.91 8.08% | -1.65 57.77% | |
payables turnover | 0.00 - | 0.59 92,372.84% | 0.65 9.80% | 2.78 325.64% | ||||
receivables turnover | 0.26 - | 1.63 536.40% | 1.95 20.00% | 2.83 44.70% | ||||
research and ddevelopement to revenue | 144.31 - | 2.36 98.37% | 0.95 59.54% | 0.64 33.40% | ||||
return on tangible assets | -0.18 - | -0.36 104.56% | -0.32 12.78% | -0.31 1.96% | -0.57 84.14% | -0.69 20.01% | -0.45 34.44% | |
revenue per share | 0.01 - | 0.60 5,450.83% | 1.92 221.06% | 2 4.41% | ||||
roe | -0.19 - | -0.45 136.35% | -0.38 13.70% | -0.53 37.42% | -1.54 191.78% | 7.45 583.27% | 6.83 8.37% | |
roic | 0.50 - | 18.86 3,702.54% | -0.43 102.28% | -0.72 67.99% | -1.46 102.27% | -3.61 146.75% | -3.16 12.43% | |
sales general and administrative to revenue | 221.97 - | 5.39 97.57% | 1.78 66.99% | 1.23 30.97% | ||||
shareholders equity per share | 10.43 - | 4.84 53.63% | 7.39 52.85% | 7.88 6.59% | 2.92 63.00% | -0.53 118.11% | -0.39 26.23% | |
stock based compensation to revenue | 32.51 - | 0.69 97.89% | 0.22 68.24% | 0.22 0.37% | ||||
tangible asset value | 144.94M - | 103.99M 28.26% | 187.03M 79.86% | 260.27M 39.16% | 110.08M 57.71% | -20.11M 118.27% | -16.66M 17.15% | |
tangible book value per share | 10.43 - | 4.84 53.63% | 7.39 52.85% | 7.88 6.59% | 2.92 63.00% | -0.53 118.11% | -0.39 26.23% | |
working capital | 145.33M - | 104.04M 28.41% | 191.85M 84.40% | 367.42M 91.51% | 248.43M 32.39% | 159.46M 35.81% | 170.54M 6.95% |
All numbers in USD (except ratios and percentages)